Change of Registered Office Address

Summary by AI ^BETAClose X

Zotefoams plc has officially changed its registered office address to Salisbury House, Finsbury Circus, London, England, EC2M 7AQ, effective immediately following Board approval on January 21, 2026. This administrative update has been filed with Companies House and is now reflected on the public register.

Disclaimer*

Zotefoams PLC

27 January 2026

Zotefoams plc

(the 'Company')

Change of Registered Office Address

27 January 2026

Zotefoams plc (the "Company") announces that, following approval by the Board on 21 January 2026, the Company has filed the necessary documentation with Companies House to update its registered office address.

The Company's registered office has now changed to:

Salisbury House, Finsbury Circus, London, England, EC2M 7AQ

This change is effective immediately and has been reflected on the public register.

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide across three market verticals, Consumer & Lifestyle, Transport & Smart Technologies, and Construction & Other Industrial. Zotefoams uses its own materials to manufacture T-FIT® advanced insulation for demanding industrial markets.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END